This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Physicians Realty Trust (DOC) Meets Q4 FFO Estimates
by Zacks Equity Research
Physicians Realty Trust (DOC) delivered FFO and revenue surprises of 0% and 1.82%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
What to Expect From VICI Properties (VICI) in Q4 Earnings?
by Zacks Equity Research
VICI Properties' (VICI) Q4 earnings are likely to reflect the company's accretive expansion moves and the benefits of owning a high-quality portfolio with a diverse revenue base.
VICI Properties Inc. (VICI) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Get a deeper insight into the potential performance of VICI Properties Inc. (VICI) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
The Zacks Analyst Blog Highlights Eagle Bancorp Montana, Duke Energy, Kinder Morgan, VICI Properties and Tyson Foods
by Zacks Equity Research
Eagle Bancorp Montana, Duke Energy, Kinder Morgan, VICI Properties and Tyson Foods are part of the Zacks top Analyst Blog.
5 Safe Stocks to Buy as Inflation Rattles Wall Street
by Tirthankar Chakraborty
With hotter-than-expected inflation spooking Wall Street, it's prudent for investors to invest in safe stocks such as Eagle Bancorp Montana (EBMT), Duke Energy (DUK), Kinder Morgan (KMI), VICI Properties (VICI) and Tyson Foods (TSN).
VICI Properties Inc. (VICI) Stock Moves -0.03%: What You Should Know
by Zacks Equity Research
VICI Properties Inc. (VICI) concluded the recent trading session at $29.71, signifying a -0.03% move from its prior day's close.
Welltower (WELL) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Welltower's (WELL) Q4 earnings are likely to have benefited from the rise in senior citizen healthcare expenditure and accretive capital deployment activity.
Vornado (VNO) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Although Vornado (VNO) has premium office assets in key markets, its Q4 performance is likely to be affected by the choppy office real estate market environment and high interest expenses.
What's in Store for Federal Realty (FRT) This Earnings Season?
by Zacks Equity Research
Federal Realty's (FRT) fourth-quarter results are likely to gain from the healthy fundamentals of the retail real estate market with limited availability of retail space.
What's in the Cards for Healthpeak (PEAK) This Earnings Season?
by Zacks Equity Research
Healthy demand for Healthpeak's (PEAK) lab assets and a rise in senior citizens' healthcare expenditure are expected to have benefited its Q4 earnings despite high interest expenses.
Regency Centers (REG) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Healthy demand for Regency Centers' (REG) shopping centers and strategic acquisitions are likely to have benefited the company's Q4 earnings. However, higher interest rates might have ailed.
VICI Properties Inc. (VICI) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
The latest trading day saw VICI Properties Inc. (VICI) settling at $29.83, representing a +0.67% change from its previous close.
What's in the Cards for Kimco (KIM) This Earnings Season?
by Zacks Equity Research
The resilient demand for Kimco's (KIM) grocery-anchored centers, a diverse tenant base and a focus on mixed-use assets are likely to have aided its Q4 earnings despite higher interest expenses.
What's in Store for Mid-America Apartment (MAA) in Q4 Earnings?
by Zacks Equity Research
Mid-America Apartment's (MAA) Q4 results are likely to reflect the healthy demand for apartment units in its markets despite the rising supply.
What's in Store for Simon Property (SPG) This Earnings Season?
by Zacks Equity Research
While Simon Property (SPG) is poised to benefit from its efforts to support omnichannel retailing and solid balance sheet strength, high interest rates are likely to have acted as a spoilsport.
UDR Readies to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
UDR's Q4 earnings are likely to have gained from portfolio diversification and technological initiatives, though high supply and elevated interest rates are likely to have acted as dampeners.
The Zacks Analyst Blog Highlights American Tower, Welltower, VICI Properties, Kimco Realty and CBRE
by Zacks Equity Research
American Tower, Welltower, VICI Properties, Kimco Realty and CBRE are part of the Zacks top Analyst Blog.
What to Expect From AvalonBay (AVB) This Earnings Season?
by Zacks Equity Research
While AvalonBay's (AVB) Q4 results are likely to show the benefits of its diversified portfolio and technological initiatives, high supply is likely to have acted as a spoilsport.
4 REITs Likely to Emerge Victorious This Earnings Season
by Moumita C. Chattopadhyay
With the REIT industry offering a real estate structure for several economic activities - real or virtual - there are pockets of strength. This is likely to be reflected in the earnings releases of AMT, WELL, VICI and KIM.
VICI Properties Inc. (VICI) Ascends But Remains Behind Market: Some Facts to Note
by Zacks Equity Research
In the most recent trading session, VICI Properties Inc. (VICI) closed at $30.43, indicating a +0.1% shift from the previous trading day.
What's in Store for Equity Residential (EQR) in Q4 Earnings?
by Zacks Equity Research
Equity Residential's (EQR) Q4 results are likely to benefit from its portfolio diversification efforts and technology investments, though high supply is likely to have played a spoilsport.
Will Strong Commissions Aid MarketAxess' (MKTX) Q4 Earnings?
by Zacks Equity Research
MarketAxess' (MKTX) Q4 results are likely to reflect gains from an increased credit trading volume on a well-performing international business. High operating costs are likely to have ailed.
Key Factors to Impact Boston Properties' (BXP) Q4 Earnings
by Zacks Equity Research
Healthy demand for Boston Properties' (BXP) premium office and life-science assets is likely to have benefited its Q4 earnings. However, higher interest expenses might have hurt the company.
Alexandria (ARE) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
While Alexandria's (ARE) Q4 earnings are likely to have benefited from the healthy demand for its high-quality life science and lab office properties, high-interest expenses and economic uncertainty raise concern.
Boston Properties (BXP) Inks Lease Extension in Santa Monica
by Zacks Equity Research
Boston Properties' (BXP) securing of lease extension with Snap at Santa Monica Business Park highlights healthy demand for the creative campus.